FIRST AMENDMENT TO THE DATA TRANSFER, CLINICAL TRIAL AND MARKET SUPPLY AGREEMENTMarket Supply Agreement • August 13th, 2002 • Intermune Inc • Pharmaceutical preparations
In the technical protocols [*], the Parties have exchanged a work plan setting forth the development work to which they have agreed (the "Work Plan"). [*] for the work under the Work Plan are as set forth below in this Appendix D.
DATA TRANSFER, CLINICAL TRIAL AND MARKET SUPPLY AGREEMENTMarket Supply Agreement • March 13th, 2006 • Intermune Inc • Pharmaceutical preparations
THIS DATA TRANSFER, CLINICAL TRIAL AND MARKET SUPPLY AGREEMENT (the “Agreement”), is made effective as of the 3rd day of November, 2005 (the “Effective Date”) by and between InterMune, Inc. (“InterMune”), a California corporation, having an address at 3280 Bayshore Boulevard, Brisbane, California 94005, USA, and Boehringer Ingelheim Austria GmbH (“BI Austria”), an Austrian corporation, having its registered office at Dr. Boehringer-Gasse 5 — 11, A-1121 Vienna, Republic of Austria. InterMune and BI Austria may be referred to herein each individually as a “Party” and jointly as the “Parties.”
